Imaging Diagnostic Systems (fka IMDS)

[laurek]

Ticker: IMDS
Company Name: Imaging Diagnostic Systems
Current Price Per Share: .0005
Short Term PPS Target: Multi cents.
Long Term PPS Target: Multi dollars.


This week IMDS has been getting a lot of buzz. Take a look at the huge following that IMDS is building up on Twitter. When these big name Twitter alerters tweeted about $IMDS' potential, that brought tens to hundreds of thousands of eyes to the company.

Shakerzzz alert obviously...and a lot of other twitter alerts including these groups:
http://twitter.com/shakerzstocks

https://twitter.com/intent/user?screen_name=StockTamer

https://twitter.com/#!/search?q=%23StockTradersTalk

https://twitter.com/intent/user?screen_name=STTRadio2

https://twitter.com/LogiCoolStocks

All other twitter streaming info: http://www.nasdaq.com/symbol/imds/stream

IMDS(.0005) profiled by Microcap Universe:
http://www.microcapuniverse.com/profile_info.php?ID=3083


Fans of Technical Analysis (T/A), check out this annotated chart:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77282434

IMDS' --CTLM-- ON SHIMADZU WEBSITE:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77231188

$IMDS, SHIMADZU MEDICAL, & MISC INFO.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77255201

$IMDS >> MUST READ POST CLINICAL TRIAL DATA:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77243257

$IMDS >> BIOSCAN, INC. ROYALTY FEE TO IMDS:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77027291

$IMDS >> CERTIFICATIONS:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76848934

$IMDS FROM LAST MONTH PR
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76726770

Short position...it's still around 1.5 billion shares:
$IMDS >> IMPORTANT
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76561788

--> Margin call for (legal) short cover is $2.50

6 REASONS WHY IMDS WILL BE TRADING AT $5-10/SHARE IN A YEAR:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76835997

THIS ARTICLE CAME OUT TODAY 6-10-12:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76458985

MUST READ DD COMPILED POST:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76285326



....A/S Increase and take-over explanation:

IMDS previously traded at $6.50 per share in 2000, prior to the ex-CEOs death in 2001. The ex-CEO is the deceased husband of the current CEO who we all know volunteered for her current position in the company a few years later. Since the death of the CEO, hedge funds have been aggressively shorting the stock to its current price in order to re-accumulate the shares and force a buyout of the CEO's stake in the company and all 35 patents, and of course that includes the LILA technology under development by Bioscan (which Bioscan is paying royalties for). The reasons we suspect an attempted take over are:

1) Its not uncommon for hedgies backed by deep pockets to force competition out through the bankruptcy process or forced buyout. Think about it...the breast mammography market is controlled by only 4 companies in the USA. The rest were either bought out or smothered into non-existence

2) Back in May when we started watching IMDS on the L2, the price action at the time was not indicative to dilution though prior to that month there was dilution hence the S-wave down in the chart. Shorts would short and cover into the newly issued shares. This was also around the time Shimadzu signed on as a distributor and we got into wondering why the hell a company of that magnitude would be involved in what appeared to be a failing company. And as I dug deeper, the aggression from the trolls on the stock message boards increased, and the short sellers threw up some heavy numbers each day on the ask, which has since diminished because I now believe the legal float is just about locked.

3) The filing for the A/S increase described how it was for ongoing capital and what not, but out of NOWHERE and I mean NOWHERE there was this sentence: "It is to be used as an anti-takeover device." And got me thinking into who was trying to take them over, and the pieces started coming together. Not to mention the CEO took away voting rights of shareholders obviously because those hedgies would have voted against her.

Since investors have bought into the stock, not only has the stock price oscillated sideways, but it also voids dilution, because we all know with dilution stock prices go down to maintain the same market cap. Volume has dropped in the last couple months, and we still see the stock price closing green. That chunk of $756,000 that was supposed to hit the market come June 30, never did, and that means their debt and all conversions have been taken care of. Shimadzu is also submitting their application to Australia as we speak so when that approval comes count on their being MILLIONS upon MILLIONS of revenue even before the next 10Q comes out, and even before FDA approval.

Looking to be the comeback of the century, in multi-monopoly fashion. The delay in news this week is also because we believe the FDA application is being submitted which takes a couple weeks.

Supersubpennies: $IMDS Due Diligence - Huge Momentum Coming Alert!

Don't miss out on this once in a lifetime opportunity. Get in before you have to chase. Current prices are a bargain.

Good luck to all.

Don't invest money that you can't afford to lose, as with any other stock. The words contained in this email are the author's opinions only, and should not be the deciding factor for any investment or trade. Do your own due diligence before making a decision. Be sure to take profits as you see fit. The author is not a financial advisor, broker, or expert. Please note that the author does hold a position in IMDS and may be biased. This email is not compensated. If you would like to unsubscribe from this email list, please email back saying "unsubscribe" in the subject. Once again, the author WILL NOT be held liable for any investing decision you make. There will be no sell alert, that is your own responsibility.